about
Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects.Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controlsEffects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney diseaseEffect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidneyCardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial.Changes in urinary excretion of water and sodium transporters during amiloride and bendroflumethiazide treatment.Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertensionEffect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjectsEffects of atorvastatin on systemic and renal nitric oxide in healthy man.Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study.Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.Effect of Cholecalciferol Supplementation During Winter Months in Patients With Hypertension: A Randomized, Placebo-Controlled TrialEffect of Nitric Oxide Inhibition on Blood Pressure and Renal Sodium Handling: A Dose–Response Study in Healthy ManEffect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series
P50
Q33838160-F6E1C612-2B90-4FF7-ABA0-F5FA6C7BD2A9Q33891603-192B0697-2639-4AD3-9B4F-4198ACDB8F50Q34554416-83679F51-A987-403D-A055-585E72F22F9CQ34868253-275B7E63-A314-4AEB-B200-EB66990C80A2Q34997788-F4568E3C-5387-4E50-89BB-F48ECA12EA05Q35128801-BFF103E1-A3BA-4608-B269-1E290978AD7FQ35819447-A39C08E7-B3D6-4B4A-AA0D-E34570F188EEQ36072467-EE8EDF1F-283B-4C73-81B1-9A18DFDA1778Q36306545-23FF0183-1F36-4192-8487-522E6D993BADQ45601973-2AAC78A6-6F6C-46FE-8F9C-A122E8F56949Q46482440-582BDF3E-0A6E-44CF-91F6-88AB13D8C9A8Q48162591-D877027C-936F-4AA1-A833-636F948C1B30Q55412511-D4028212-EB79-4ECE-8C24-326EB8760A18Q59106879-191912E5-D5E2-4809-940D-10F4E000ED3CQ59106899-BD792235-7A16-4C87-9784-F788C9C11ECFQ64990045-67CB0E9A-5424-4147-83A1-A7CE8EE457B9Q88220394-CE8813EE-36B3-4242-BEDC-4373EF0F9DB3
P50
description
researcher ORCID ID = 0000-0002-5830-5814
@en
wetenschapper
@nl
name
Frank H Mose
@ast
Frank H Mose
@en
Frank H Mose
@nl
type
label
Frank H Mose
@ast
Frank H Mose
@en
Frank H Mose
@nl
prefLabel
Frank H Mose
@ast
Frank H Mose
@en
Frank H Mose
@nl
P31
P496
0000-0002-5830-5814